Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS)

Søren R. Kristensen; Bo Abrahamsen; Jonna Skov Madsen; Jørgen Gram; Lars Rejnmark; Bo Rud; Jørgen Jespersen

doi:10.1160/TH05-12-0824

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(05): 915-916
DOI: 10.1160/TH05-12-0824

Letters to the Editor

Schattauer GmbH

Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS)

Søren R. Kristensen

¹Department of Clinical Biochemistry, Cardiovascular Research Center, Aalborg Hospital, Århus University Hospital, Aalborg

,

Bo Abrahamsen

²Department of Endocrinology

,

Jonna Skov Madsen

³Department of Clinical Biochemistry, Odense University Hospital, Odense C

,

Jørgen Gram

⁴Department of Clinical Biochemistry, Ribe County Hospital, Esbjerg, Department for Thrombosis Research, University of Southern Denmark

,

Lars Rejnmark

⁵Department of Endocrinology and Metabolism C, Aarhus Sygehus, Aarhus University Hospital, Aarhus

,

Bo Rud

⁶Department of Osteoporosis Research, Hvidovre Hospital, Hvidovre; Denmark

,

Jørgen Jespersen

⁴Department of Clinical Biochemistry, Ribe County Hospital, Esbjerg, Department for Thrombosis Research, University of Southern Denmark

› Author Affiliations

Abstract

Full Text

References

References
1 Daly E, Vessey MP, Hawkins MM. et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80.
2 Jick H, Derby LE, Myers MW. et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. lancet 1996; 348: 981-3.
3 Daly E, Vessey MP, Painter R. et al. Case-control study of venous thromboembolism risk in users of hormone replacement therapy. Lancet 1996; 348: 1027.
4 Grodstein F, Stampfer MJ, Goldhaber J. et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-7.
5 Perez SGutthann, Garcia LARodriguez, Castellsague J. et al. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997; 314: 796-800.
6 Grady D, Wenger NK, Herrington D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Int Med 2000; 132: 689-96.
7 Writing group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
8 The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701-12.
9 Høibraaten E, Abdelnoor M, Sandset PM. Hormone replacement therapy with estradiol and risk of venous thromboembolism. Thromb Haemost 1999; 1218-21.
10 Mosekilde L, Hermann AP, Beck-Nielsen H. et al. The Danish osteoporosis prevention study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999; 31: 207-19.